<b>Objectives</b>: To evaluate the diagnostic performance of pentraxin 3 (PTX3) in plasma and bronchoalveolar lavage fluid (BALF) for invasive pulmonary aspergillosis (IPA) in non-neutropenic patients. This evidence concerns the gene PTX3 and Ito hypomelanosis.